Itron (NASDAQ:ITRI) Downgraded to “Hold” Rating by Wall Street Zen

Itron (NASDAQ:ITRI) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday.

A number of other equities analysts have also commented on the stock. Oppenheimer set a $145.00 price objective on shares of Itron and gave the stock an “outperform” rating in a research note on Friday, October 31st. Baird R W cut Itron from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 31st. Argus reissued a “hold” rating on shares of Itron in a research report on Tuesday, November 4th. Johnson Rice raised Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price objective for the company in a research note on Monday, January 5th. Finally, Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Itron in a research note on Monday, December 29th. Nine research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $138.10.

Itron Price Performance

Shares of NASDAQ ITRI opened at $99.28 on Wednesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.17 and a quick ratio of 1.91. The firm has a market capitalization of $4.55 billion, a PE ratio of 17.86, a P/E/G ratio of 0.54 and a beta of 1.49. Itron has a 1-year low of $90.11 and a 1-year high of $142.00. The business’s fifty day moving average price is $97.61 and its two-hundred day moving average price is $116.68.

Itron (NASDAQ:ITRI) last issued its quarterly earnings data on Thursday, October 30th. The scientific and technical instruments company reported $1.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.48 by $0.06. Itron had a return on equity of 17.82% and a net margin of 10.69%.The business had revenue of $581.63 million during the quarter, compared to the consensus estimate of $578.49 million. During the same period in the previous year, the firm posted $1.84 earnings per share. The business’s revenue was down 5.5% on a year-over-year basis. Itron has set its FY 2025 guidance at 6.840-6.940 EPS and its Q4 2025 guidance at 2.150-2.250 EPS. On average, research analysts expect that Itron will post 5.33 EPS for the current year.

Insider Activity

In other news, SVP Christopher E. Ware sold 343 shares of the company’s stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $96.51, for a total transaction of $33,102.93. Following the completion of the transaction, the senior vice president directly owned 18,774 shares in the company, valued at $1,811,878.74. The trade was a 1.79% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP John F. Marcolini sold 553 shares of the business’s stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $96.51, for a total transaction of $53,370.03. Following the transaction, the senior vice president owned 13,843 shares in the company, valued at approximately $1,335,987.93. The trade was a 3.84% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 2,971 shares of company stock valued at $286,731. Insiders own 1.51% of the company’s stock.

Institutional Investors Weigh In On Itron

Large investors have recently bought and sold shares of the business. Oliver Luxxe Assets LLC lifted its position in Itron by 0.5% during the 4th quarter. Oliver Luxxe Assets LLC now owns 24,960 shares of the scientific and technical instruments company’s stock valued at $2,318,000 after purchasing an additional 127 shares during the period. Green Alpha Advisors LLC raised its stake in shares of Itron by 9.6% during the fourth quarter. Green Alpha Advisors LLC now owns 5,790 shares of the scientific and technical instruments company’s stock worth $538,000 after buying an additional 508 shares during the last quarter. Davis Investment Partners LLC raised its stake in shares of Itron by 3.0% during the fourth quarter. Davis Investment Partners LLC now owns 5,163 shares of the scientific and technical instruments company’s stock worth $488,000 after buying an additional 150 shares during the last quarter. Mirabella Financial Services LLP acquired a new position in Itron in the third quarter valued at approximately $226,000. Finally, Tudor Investment Corp ET AL boosted its stake in Itron by 47.2% in the third quarter. Tudor Investment Corp ET AL now owns 274,644 shares of the scientific and technical instruments company’s stock valued at $34,210,000 after acquiring an additional 88,029 shares during the last quarter. 96.19% of the stock is currently owned by institutional investors.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.